Access cutting-edge scleroderma treatment through this clinical trial at a research site in Baltimore. Study-provided care at no cost to qualified participants.
Access scleroderma specialists in Baltimore at no cost
This study follows strict safety protocols and ethical guidelines
All study-related scleroderma treatment provided free
This is a Phase II randomized, double-blind, placebo-controlled trial of sildenafil in men and women with Scleroderma with mildly elevated pulmonary pressures (SSc-MEP) to determine whether sildenafil may be an effective treatment for SSc-MEP.
Sponsor: Johns Hopkins University
Check if you qualify for this scleroderma clinical trial in Baltimore, MD
If you're searching for scleroderma treatment options in Baltimore, MD, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Baltimore research site is actively enrolling participants for this clinical trial. You'll receive care from experienced scleroderma specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.